title: Review of clinical trials on effects of oral antioxidants on basic semen and other parameters in idiopathic oligoasthenoteratozoospermia.
abstract: Infertility affects 50 to 80 million people worldwide. Male factor is a cause of infertility in almost half of cases, mainly due to oligoasthenoteratozoospermia (OAT). With common diagnostic methods no cause can be found in approximately 30% of cases of male infertility due to OAT and these are considered idiopathic. Reactive oxygen species (ROS) play an important role in male infertility and are proved to be higher in infertile men; antioxidants could oppose their effect. The aim of this paper was to review the literature on clinical trials in the period from year 2000 to year 2013 studying the effects of various types of antioxidant supplements on basic and other sperm parameters and pregnancy rates in subfertile males with idiopathic OAT. The majority of studies were randomized and placebo controlled and confirmed beneficial effect of antioxidants on at least one of the semen parameters; the biggest effect was determined on sperm motility. In many of these trials combinations of more antioxidants were assessed. The optimal dosages of one or more antioxidants were not defined. We concluded that antioxidants play an important role in protecting semen from ROS and can improve basic sperm parameters in case of idiopathic OAT.
authors.affiliation: Reproductive Unit, Division of Gynecology and Obstetrics, University Medical Centre Ljubljana, Slajmerjeva 3, 1000 Ljubljana, Slovenia.
authors.forename: Senka
authors.identifier: 0000-0002-4421-7266
authors.initials: S
authors.lastname: Imamovic Kumalic
authors.affiliation: Reproductive Unit, Division of Gynecology and Obstetrics, University Medical Centre Ljubljana, Slajmerjeva 3, 1000 Ljubljana, Slovenia.
authors.forename: Bojana
authors.identifier: 0000-0001-6521-4593
authors.initials: B
authors.lastname: Pinter
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000008:administration & dosage*; D053627:Asthenozoospermia / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000453:epidemiology*; D018873:Pregnancy Rate; D013076:Sperm Count / Q000706:statistics & numerical data*; D013081:Sperm Motility / Q000187:drug effects*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000975:Antioxidants